TY - CHAP M1 - Book, Section TI - Cardiac Surgical Intervention in Pediatric Patients with Connective Tissue Disorders A1 - Zanotti, Giorgio A1 - Cameron, Duke E. A1 - Vricella, Luca A. A2 - Yuh, David D. A2 - Vricella, Luca A. A2 - Yang, Stephen C. A2 - Doty, John R. Y1 - 2014 N1 - T2 - Johns Hopkins Textbook of Cardiothoracic Surgery AB - Thoracic aortic aneurysm syndromes are due to genetic disorders inherited as autosomal dominant traits with reduced penetrance and incomplete expression. Hence, clinical phenotype is complex and highly variable with often no genotype-phenotype correlation.Altered TGF-β signaling and proteolytic metabolism involving the entire aortic wall are now challenging old pathophysiologic models by which aortic aneurysms were solely caused by extracellular matrix structural protein deficiency in the media.Indications for surgery are still mainly based on aortic diameter as well as aortic growth rate and family history of early rupture/dissection. However, efforts are made to identify circulating markers associated with early complications to guide risk stratification.Surgery is the only treatment that can modify the natural history of pediatric patients with thoracic aortic aneurysm syndromes. Although promising, medical treatment has not yet been validated.Aortic valve-sparing root replacement (AVSRR) is currently the favored surgical approach, whereas the Bentall operation should be reserved for patients with acute aortic dissection, unrepairable leaflet damage, or failed AVSRR. Early and midterm results of AVSRR in pediatric patients are excellent and comparable to those obtained with composite valve graft root replacement. Long-term event-free survival in this particular group of patients has yet to be assessed. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/04/18 UR - accesssurgery.mhmedical.com/content.aspx?aid=1104598462 ER -